Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Ruffena Capital

Ruffena Capital
GROWTH INVESTOR TYPE
Active STATUS
16 PROFESSIONALS
38 INVESTMENTS
31 PORTFOLIO
8 EXITS
Description

Ruffena Capital is a boutique private equity advisory business with its own investment platform - focused on raising true growth capital or alternative finance. Its investors are largely a private audience of the experienced UK and international investors, funds, family offices and certain wealth managers, who prefer established, highly tangible opportunities that can demonstrate the ability to scale and generate returns. The firm was founded in 2013 and is based in London, United Kingdom.

Investor Status
Actively Seeking New Investments
Year Founded
2013
Primary Investor Type
Growth/Expansion
Other Investor Types
PE/Buyout
Venture Capital
Primary Office
  • 7 Stratford Place
  • Marylebone
  • London W1C 1AY
  • England, United Kingdom

+44 020 0000 0000

Ruffena Capital Investments (38)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
000000 27-Jun-2019 00 000000000 00.000 Industrial Supplies and Parts Generating Revenue
0000000000 0000000 31-May-2019 00 000000000 00000 Business/Productivity Software Generating Revenue 00000 0000
00000-0000 01-Apr-2019 00 000000000 Road Generating Revenue
000000000000 01-Feb-2019 00000 00000 00.000 Financial Software Generating Revenue
BuyFair 01-Jan-2019 Early Stage VC 00000 Other Commercial Services Startup
To view this investor’s complete investment and acquisition history, request access »
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Ruffena Capital’s full profile, request a free trial.

Ruffena Capital Exits (8)

Company Name Exit Date Exit Type Exit Size Status Buyers
00 0000 00000000 27-May-2018 0000000000 00000 Completed
  • 2 buyers
0000000000 29-Mar-2018 0000000000: 000000 Completed
000000000 00000000 10-Nov-2017 000000000000000000 Completed
  • 000000000
0000000000 05-Sep-2017 000 000.00 Completed
Destiny Pharma 04-Sep-2017 IPO 000.00 Completed
  • 2 buyers
To view this investor’s complete exits history, request access »

Ruffena Capital Team (22)

Name Title Deals Funds Boards Office Contact
Info
Robin Hill Chief Executive Officer & Founder 0 London, United Kingdom
Bernard Cummings Partner London, United Kingdom
Maarten van den Belt Partner London, United Kingdom
Patrick Angier Partner 0 London, United Kingdom
Dwight Makins Director 0 London, United Kingdom

6 Former Team Members

You’re viewing 5 of 22 team members. Get the full list »